market-trends is the sole category represented across all 2 tracked stories. Ron Vachris is most often covered alongside Medicare Advantage, which appears in 2 of these 2 stories. They are less corroborated than the beat average, carrying 2 original sources each against 2.3 for the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Ron Vachris
market-trends is the sole category represented across all 2 tracked stories. Ron Vachris is most often covered alongside Medicare Advantage, which appears in 2 of these 2 stories. They are less corroborated than the beat average, carrying 2 original sources each against 2.3 for the same window. The 6 average consequence score is above the beat benchmark of 5.8 in the same window. We currently track 2 Healthcare stories that mention Ron Vachris, published between August 18, 2026 and August 19, 2026.
Stories tracked
2
Sources per story
2
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 20 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Ron Vachris. Shared-story counts are live from our verified record — not editorial picks.
Costco and SCAN Health Plans are testing a senior-focused Medicare Advantage pilot across three undisclosed markets. The plans include prescription drug, vision, OTC, food, and hearing benefits, with no membership requirement and no public timeline due to regulatory limits.
Costco is joining nonprofit insurer SCAN to launch a co-branded Medicare Advantage plan that folds pharmacy, vision, hearing, and OTC services into senior coverage. The initial three-state footprint would reach about 5 million Medicare enrollees.